MAPK3 and central nervous system cancer: Our results showed that PTE did not change the total levels of ERK1/2, JNK, and P38 in glioma cells while significantly increasing the phosphorylation levels of ERK1/2 and JNK, but had no significant effects on phosphorylation levels of p38.